Mission statement · Company scope
“Our mission is to become a global leader in developing better and safer radioimmunotherapy and antibody-based oncology therapies addressing clear unmet medical needs and, as such, have a transformational impact on the lives of patients.”
In use2025 – now1 sighting
First seenMar 2025Added
Last seenMar 2025Latest observation
Date created—Not published by the organization
Record
- Kind
- Mission
- Scope
- Company
- Style
- Market leadership (primary) · Impact · Problem–solution
- Leads with
- Rank
- Best for
- Climate & health
- Formula
- The [rank] [category] for [who]
- Tone
- Plain
- Length
- 35 words · reading grade 22.1
- Review status
- unreviewed · classifier rules-v0
- Quality score
- 0.74
- Record
- st_799fe723364b62d2
- Classification confidence
- 0.67
Sources1 sighting
SEC
SEC EDGAR filingsObserved 2025-03-04 · sec_sentence · 10-K · accession 0001558370-25-002105
View filing ↗0 to compareCompare